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230 K.T.D. Thai et al.and 283 secondary infections were included in this study. In 25% (86/351) dengue virus (DENV) was
detected by RT-PCR among which 32 DENV-1, 16 DENV-2, 1 DENV-3 and 37 DENV-4 were identified.
The predominant dengue serotype varied by yearwith seasonal fluctuation: DENV-4 in 2001e2002,
DENV-1 and DENV-2 from 2003 to 2006. Primary dengue was more common in children. Higher vir-
aemia levels (PZ 0.010) were found in primary infections compared to secondary infections.
DENV-1 infected patients had higher viraemia levels than DENV-2 (PZ 0.003) and DENV-4
(P< 0.001) infectedpatients. Clinical symptomswere often seen in adults. Fewdifferences in clin-
ical symptomswere found between primary and secondary infection and no significant differences
in clinical symptoms between the serotypes were observed.
Conclusions: Our data provide insight in the epidemiology, clinical profile and virological features
of mild symptomatic dengue patients who presented to PHC with AUF in Vietnam.
ª 2010 The British Infection Society. Published by Elsevier Ltd. Open access under CC BY license. Introduction
Mosquito-borne flavivirus infections such as dengue have
rapidly spread and are now one of the most important
infectious diseases in the world, in terms of morbidity
and mortality.1,2 It is a public health problem with grow-
ing global incidence and geographic distribution to almost
all tropical and subtropical regions, and with a transition
from epidemic to endemic transmission intensity. Recent
estimates indicate that over 3.5 billion people (w55%) of
the world population are living in areas at risk for
dengue.3
Dengue is caused by an infection with a dengue virus
(DENV) and transmitted primarily by Aedes spp. mosquito
vectors.4 Any of the four distinct serotypes (DENV 1e4)
can cause dengue fever (DF) or the more severe forms of
the diseases: dengue hemorrhagic fever/dengue shock syn-
drome (DHF/DSS).5 The majority of DENV infections are
probably asymptomatic, and only a small number of dengue
infections (w5%) will result in severe forms of the disease.6
The mechanisms for the variable clinical course are not
completely elucidated, but interactions between virus
and host immunity and hyperendemicity of multiple sero-
types are believed to play an important role in determining
the outcome of disease.7
In Vietnam, dengue is not only an urban disease but
also the high population density and ecological conditions
in the rural areas are also favourable for dengue trans-
mission. Binh Thuan, a rural province in southern Viet-
nam, is highly endemic for dengue.8 Dengue usually
presents as a nonspecific febrile illness and is rarely rec-
ognized as a clinical entity by physicians at primary
health centers (PHC).9 However, recent studies have sug-
gested that dengue is the most frequent cause of fever in
patients who present to the PHC and is responsible for
approximately one-third of all patients with fever.10 The
prevalence of dengue IgG antibodies among primary
school children increased from 50% to 90% with increasing
age, indicating high, relatively stable, transmission rates
over many years. The annual sero-conversion rate among
primary school children, corresponding to the annual inci-
dence rate of primary dengue infections, ranged from 12
to 17%.11,12
The data presented here are derived from a prospective
observational study from March 2001 to March 2006, with
enrolment of acute undifferentiated fever (AUF) patients
who presented to 12 PHCs and the provincial malariacontrol center in Binh Thuan province.9,10 One of the ob-
jectives was to describe the epidemiology and to detect
outbreaks of dengue in Binh Thuan province. In dengue
endemic regions, outbreaks often do not necessarily re-
flect an increase in transmission intensity but merely an
increased number of patients with complicated dengue,
mostly secondary infections after the (re-)introduction
of a new serotype.13 During the study period no significant
outbreaks of dengue were observed, other than the usual
seasonal fluctuation. Here, we report PCR results for pa-
tients with serologically confirmed dengue and analyze
the epidemiology and clinical and virological characteris-
tics with respect to serotype, antibody response and
viraemia.Material and methods
Study site and population
The study site was described previously.9,10 Binh Thuan
Province is located along the south-eastern coast of Viet-
nam, 150 km northeast of Ho Chi Minh City. It covers
7828 km2 and the estimated population was 1,140,429 in-
habitants in 2004.
A prospective observational study was conducted from
March 2001 to March 2006. In this study, patients with
AUF, who presented to the 12 study PHC and at the
provincial malaria control station center in Phan Thiet
city, were included. Patients were invited to participate
after giving informed consent. A standardized question-
naire was taken to collect demographic and clinical
information. Serum samples were collected by venous
puncture on presentation (acute sample; t0) and after 3
weeks (convalescent sample; t3). Serum samples were
stored at 20 C at the study sites until monthly transfer
to Cho Ray hospital (Ho Chi Minh City, Vietnam), where
they were stored at 70 C.
Sample selection for serology and PCR
Complete sets of acute and convalescent samples were
collected for serology. In 2001 all collected paired sera
were tested with dengue ELISA; from 2002 onwards
paired samples were randomly selected as two patients
per PHC and per month from the total dataset.10 Firstly,
serum specific anti-dengue IgM- and IgG-ELISA were
Clinical, epidemiological and virological features in DENV infections 231performed in sera patients with AUF.14 Based on the sero-
logical results, patients with DENV infection were
included in this study. Secondly, RT-PCR was performed
in the acute samples of patients with serologically
confirmed dengue.
Dengue diagnostics
Paired serum samples were tested for dengue with direct
IgG ELISA and IgM-Capture ELISA (Focus Technologies Inc.,
Cypress, CA, USA). Details regarding the ELISA and the
interpretation of results have been described previ-
ously.14,15 Briefly, a fourfold increase of antibody concen-
trations between t0 and t3 was considered significant.
The IgM concentration on t3, relative to the IgG concentra-
tion on t3 was also used as a criterion. Acute primary den-
gue virus infection was defined as positive IgM on t3 with an
IgM/IgG ratio on t3 greater than one. A positive IgM on t3
with an IgM/IgG ratio on t3 less than one, or a negative
IgM reaction on t3 but with a positive IgG t3 and a fourfold
molar increase of IgG between t0 and t3 were classified as
acute secondary dengue. A negative IgM reaction on t3,
a positive IgG on t3 but without a fourfold increase be-
tween t0 and t3 was classified as ‘‘not acute dengue but
past infection’’, and a case of both negative IgM and IgG
on t3 was classified as ‘‘no dengue’’. Dengue NS1 antigen
was detected in a subset of serum samples using the Plate-
lia Dengue NS1 Ag  ELISA (Bio-Rad Laboratories, Inc.,
Hercules, CA, USA) according to the manufacturer’s in-
structions.16 Optical density (OD) was measured at 450/
620 nm, using the Evolis absorbance reader. Results
were expressed as the OD ratio (ODR) between the OD
value of the sample and a calibrator sample that is en-
closed with every test panel. An ODR 1.0 was interpreted
as positive.
RNA was isolated from serum from the first serum as
described elsewhere.17 RNA was reversely transcribed, and
dengue virus viraemia levels were assessed using an inter-
nally controlled, serotype specific, real-time reverse tran-
scriptase polymerase chain reaction (RT-PCR) assay that
has been described elsewhere; results were expressed as
cDNA equivalents per ml of serum.18
Ethical considerations
The study was approved by the Review Board of Cho Ray
Hospital, the provincial health services of Binh Thuan and
the Peoples Committees of the participating communities.
All patients (or, for children the parents or guardian) gave
written informed consent.
Statistical analysis
All results were summarized in terms of medians and ranges
for continuous data and non-parametric tests were used to
compare within groups. For dichotomous variables, Fisher’s
exact test was performed. Viraemia levels were expressed
as the median and 25e75% interquartiles (25e75 IR). All
calculations were performed using SPSS (version 16.0, SPSS
Inc. Illinois). A two-tailed p-value of <0.05 was considered
as statistically significant.Results
Sample population
A total of 14,595 febrile patients were included. Eighty-
three patients did not meet the inclusion criteria and
were excluded from further analysis. Paired sera were
collected from 8268 febrile patients; 1938 (23.4%) serum
pairs were tested with dengue an IgM- and IgG-ELISA.
Dengue was serologically confirmed in 382 (19.7%) cases.
Of these, RT-PCR was performed in 351 (91.9%) acute
samples. DENV was detectable in 86 (24.5%) samples
among which 32 were DENV-1, 16 DENV-2, 1 DENV-3 and
37 DENV-4 were detected. Serologic testing by ELISA
revealed 68 primary infections and 283 secondary in-
fections. Demographic information on the study popula-
tion is shown in Table 1.
Epidemiologic data
Occurrence of dengue serotypes
Dengue incidence in Binh Thuan peaks during the rainy
season from May to October. DENV-4 was the dominant
dengue serotype in 2001e2002. Thereafter, DENV-1 and
DENV-2 became the most frequently isolated serotype
(Fig. 1).
Distribution of primary and secondary infection by age
group
When age groups were combined from patients selected for
RT-PCR, acute secondary dengue (nZ 283) was four times
as common as acute primary dengue (nZ 68). The acute
primary/secondary dengue ratio in children (<15 years of
age) and adults were 0.49 and 0.12 (P< 0.001 by Fisher’s
exact test), respectively. Fig. 2 shows the serotypes which
were found in 86 patients and the distribution of serologi-
cally confirmed primary and secondary DENV infections
stratified by age group.
Clinical data
Differences in clinical presentation between primary and
secondary infection
Patients with secondary infection were more likely to be
older than those with primary infection (P< 0.001). The
median time between onset of fever and the first visit
was 1 day (25e75 IR, 2 days) for primary and secondary den-
gue. Myalgia was more frequently reported in secondary in-
fection, whereas gastrointestinal symptoms were more
common in primary infections (Table 2).
Differences in clinical presentation between primary and
secondary dengue with different serotypes
Primary infection was diagnosed in 17 of 32 DENV-1 patients
(53.3%) and 1 of 16 DENV-2 patients (6.3%). All DENV-4
patients (nZ 37) had an antibody response that was com-
patible with secondary dengue. No significant differences
between primary DENV-1 and DENV-2 were observed with
respect to the clinical variables. Clinical variables were
also not significantly different between secondary DENV-
1, DENV-2 and DENV-4 infections.
Table 1 Demographic data of patients with acute undifferentiated fever and dengue.
Patients with AUF (NZ 14512) Serologically confirmed/total
tested (NZ 351/1938)
Virologically confirmed/total
tested (NZ 86/351)
Male/female (ratio) 1.28a (8139/6373) 1.76 (224/127) 2.58 (62/24)
Median age (yr) (range) 18.3 (0.1e95.1)b 18.9 (4.2e73.7) 16.3(5.6e55.2)
Child/adult (ratio) 0.70 0.61 0.87
a Sex was unknown in 7 AUF patients.
b Age was unknown in 8 AUF patients.
232 K.T.D. Thai et al.Differences in clinical presentation between children and
adults
Table 2 also shows the distribution of clinical variables be-
tween children and adults. The median time between onset
of fever and the first visit was 1 day (25e75 IR, 1 days) for
both children and adults. Symptoms and physical findings
were more common in adult patients, such as myalgia,
backache, arthralgia, and bruises.Figure 1 Co-occurrence of multiple dengue viruVirologic data
Viraemia levels were measured in 71 of 86 RT-PCR positive
patients (84%); 28 of 32 DENV-1, 11 of 16 DENV-2, 1 of 1
DENV-3 and 32 of 37 DENV-4. The viraemia levels in serum
ranged from 1.5 104 to 2.7 1011/mL, with a median of
1.1 106/mL (25e75 IR, 4.1 106/mL), and were sampled
from day 0 to day 4 of fever.s serotypes in Binh Thuan from 2001 to 2006.
Figure 2 Age group distribution of serologically (nZ 1938) and RT-PCR (nZ 86) confirmed dengue virus infection and serotypes
among AUF patients in Binh Thuan province, 2001e2006.
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response
Viraemia levels were significantly higher in primary than in
secondary dengue (4.2 106/mL versus 8.8 105/mL, re-
spectively, PZ 0.010, Fig. 3A). During the first two days
of fever, viraemia levels were significantly higher in pri-
mary dengue than in secondary dengue (4.2 106/mL ver-
sus 9.6 105/mL, respectively, PZ 0.036). The
distribution of viraemia levels at different time points
since illness days in primary and secondary dengue is
shown in Fig. 3B.
Relationship between serum viraemia and the serotype
DENV-1 infected patients had higher median viraemia levels
than DENV-4 infected patients. Viraemia levels in DENV-1
infected patients were higher than in DENV-2-infected
patients. Viraemia levels in DENV-2 and DENV-4 infected
patients were not significantly different (Fig. 3C). When im-
mune status was taken into account, median viraemia levels
remained higher in secondary DENV-1 infected patients than
secondary DENV-4 (5.5 106/mL versus 8.3 105/mL, re-
spectively, PZ 0.014) and secondary DENV-2 (5.5 106/mL
versus 2.6 105/mL, respectively, PZ 0.015) infected pa-
tients. No association was observed between serum viraemia
levels and sex and age.
Relationship between serum viraemia and NS1 antigen
NS1 antigen detection was performed in 100 (of 351) acute
samples; 40 samples were NS1 antigen positive. DENV was
detectable in 31 (78%) of these samples and viraemia
levels were measured in 20 samples. DENV was demon-
strated in 3 of 60 NS1 antigen negative samples (5.0%).
Irrespective of immune status, viraemia levels were higher
in NS1 antigen positive patients than NS1 antigen negative
patients (1.7 107/mL versus 8.6 104/mL, respectively)
(PZ 0.016, ManneWhitney test). Fig. 3D shows differencesin viraemia levels among patients with and without NS1 an-
tigen by immune status. The median viraemia levels in pa-
tients with secondary DENV infections with NS1 antigen
were higher than those without NS1 antigen. Because of
the small numbers, this did not reach significance
(PZ 0.100).Discussion
In a previous study we showed that dengue is highly
endemic in Binh Thuan province in southern Vietnam.10,19
Here we show that during a study period of five years, co-
circulation of multiple DENV serotypes occurred in this
region. Higher viraemia levels were found in primary infec-
tions in comparison to secondary infections. DENV-1 in-
fected patients had higher viraemia levels than DENV-2
and DENV-4 infected patients. Clinical manifestations of
infections with the different serotypes were similar but
symptoms were more commonly observed in adults. Two
symptoms differed significantly between primary and sec-
ondary infection which were myalgia and gastrointestinal
symptoms.
The most prevalent serotype was DENV-4 during 2001
and 2002, followed by DENV-1 and DENV-2 in 2003. Although
seasonal variations in virologically confirmed dengue cases
were observed, these should be interpreted with caution,
because only a proportion of AUF patients were tested by
RT-PCR. A previous surveillance study showed that all four
DENV serotypes co-circulated in southern Vietnam in 2001
with isolation of DENV-2 and DENV-3 in Binh Thuan prov-
ince.20 This study shows that all DENV serotypes have been
circulating in Binh Thuan province, probably with a shift of
the dominant DENV serotype during the study period. Co-
circulation of all DENV serotypes is well described in Asia
and indicates hyperendemicity.21
Table 2 Frequency of symptoms and physical findings on admission in patients diagnosed with primary, secondary and chil-
dren and adults.
Variables Primary
infection
(NZ 67a)
Secondary
infection
(NZ 283)
P Children 5e15
years (NZ 132a)
Adult 15
years (NZ 218)
P
Age (yr)b 12.2 (5.3e51.7) 20.6 (5.5e73.6) <0.001 11.2 (5.3e15.0) 28.1 (15.5e73.7)
Male/female 44/23 180/103 80/52 144/74
Body temperature
(

C)b
38.9 (38.0e39.9) 39.0 (38.0e42.0) 39.0 (38.0e42.0) 39.0 (38.0e40.0)
Pulse pressure
(mmHg)b
30.0 (30.0e60.0) 40.0 (20.0e60.0) <0.001 30.0 (20.0e55.0) 40.0 (20.0e60.0) <0.001
Heart rate
(beats/min)b
90.0 (70.0e130.0) 90.0 (66.0e130.0) 95.0 (76.0e130.0) 90.0 (66.0e120.0) <0.001
Symptoms, (%)
Headache 91.0 94.7 92.4 95.0
Myalgia 29.9 52.7 0.001 25.8 61.9 <0.001
Sore throat 32.8 42.4 44.7 38.1
Backache 20.9 19.1 6.1 27.5 <0.001
Nausea 20.9 23.7 14.4 28.4 0.003
Cough 28.4 33.6 31.8 33.0
Arthralgia 16.4 17.7 10.6 21.6 0.009
Gastrointestinal
symptoms
25.4 13.1 0.022 12.1 17.4
Findings at physical
examination, (%)
Pallor 19.4 17.3 12.1 21.1 0.043
Dehydration 11.9 13.1 13.6 12.4
Pharyngitis 40.3 49.5 48.5 47.2
Lymph nodes 0.0 0.7 1.5 0.0
Rash 0.0 2.5 0.0 3.2
Bruises 6.0 4.2 0.8 6.9 0.007
a One child (ageZ 4.2 years) was excluded from analysis.
b Median (range); differences between groups were analyzed with ManneWhitney tests. Fisher’s exact test was used in all dichotomous
data. Gastrointestinal symptoms: abdominal pain, diarrhea and constipation.
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important to point out that a primary immune response
was biased towards DENV-1, which accounted for 87% of
primary DENV infections. DENV-1 infections were charac-
terized by significantly higher viraemia levels than DENV-4
infections and slightly higher than DENV-2 (Fig. 2D). DENV-1
infected patients are more likely to be younger than DENV-2
or DENV-4 infected patients. Age is an important risk factor
for the development of severe dengue disease.22
The relationship between viraemia and host antibody
response is less clear and has been the topic of many studies.
In DENV-1 infections, viraemia was higher than in secondary
infections but this pattern was not found for DENV-2 in-
fections for which lower viraemia was associated with higher
anti-DENV antibody titres.18,23e25 Interestingly, primary im-
mune status was found in half of the symptomatic DENV-1
cases whereas 100% DENV-4 and almost all DENV-2 infections
exhibited a secondary response. Likewise, primary infections
with DENV-1 were predominant compared to other serotypes
in a retrospective study of Thai dengue cases.21 Analysis of
a co-epidemic with DENV-2 and DENV-4 indicated that the
vast majority of DENV-2 infections were associated with
a secondary immune response.26DENV-2 viruses have most commonly been associated with
DHF/DSS,21,27,28 along with DENV-1 and DENV-3 viruses.29,30
DENV-2 and DENV-4 have been associated with increased dis-
ease severity as a secondary infection, whereas DENV-1 and
DENV-3 seem to cause more severe disease in primary
infection than do the other two serotypes.27,31
These data should be interpreted against their own
history of DENV co-circulation and herd immunity, which
may be different between regions. In our study, clinical
manifestations did not differ significantly among patients
infected with different serotypes but this was a study
population selected with only mild disease in a highly
endemic area with a history of circulation of all DENV
serotypes.
Our data showed sex differences with a male predom-
inance. Reported sex differences are contradicting and
differences in favour of males have been documented.32,33
The underlying causes of sex differences are not clear and
multiple factors may play a role. A plausible explanation
could be that there is a slight predominance in male births
in Vietnam.34 A biased parents’ health seeking behaviours
towards males, differences in susceptibility and clinical
presentation are other plausible causes.35
Figure 3 Distribution of viraemia levels in: (A) patients with primary and secondary dengue infections; (B) patients with primary
and secondary dengue infection and fever history; (C) patients with DENV-1, DENV-2, DENV-3 and DENV-4 infections; (D) patients
with and without NS1 antigen. All comparison within groups was performed using ManneWhitney tests. Box plots show median
values (horizontal line in the box), 25e75% interquartile range (lower-upper limits of the box), 90% range of data (additional
bars), and outliers (circles).
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of AUF patients over a period of five years which provides
a comprehensive overview of epidemiological pattern over
time at PHC in Vietnam. Only AUF patients were tested for
dengue and, therefore, the study population included
mildly symptomatic patients. Interestingly, a considerable
amount (20%) of AUF patients were seen with primary DENV
infection at PHC. Health seeking behaviour and the nature
of study site (at PHC) may have caused the identification of
more symptomatic primary dengue infections. This study
was conducted shortly after a period of time in which
malaria was the main cause of fever. Public awareness that
malaria causes fever was high. As results of which, febrile
patients presented themselves very early at PHC. Wepreviously showed that patient delay was shorter for
children, suggesting that parents are very concerned about
the health of their children and take the opportunity to
seek help as soon as possible.36 These patients are probably
a true reflection of burden of symptomatic dengue in the
general population.
A limitation of this study is that serotypes identification
by RT-PCR showed a low yield. There are several possible
explanations for this low detection rate. First, serum
samples were aliquoted and stored at 20 C up to one
month. Samples were collected for transportation to CRH
hospital for storage at 70 C once monthly. DENV RNA
could have degraded due to sub-optimal storage and trans-
port conditions. Secondly, samples were used previously for
236 K.T.D. Thai et al.other studies.9,10,14,15,19 It is possible that several freezee
thawing steps contributed to the degradation of DENV
RNA. Thirdly, the majority of our study population pre-
sented very early in course of dengue and clinical manifes-
tations were very mild. At this early stage of disease,
viraemia levels may have been low.31
In conclusion, our data confirm earlier findings that
dengue is highly endemic in southern Vietnam and shows
that all four serotypes are prevalent.Acknowledgement
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